Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2016, Article ID 5190846, 8 pages
http://dx.doi.org/10.1155/2016/5190846
Clinical Study

Effects of a Multispecies Probiotic Mixture on Glycemic Control and Inflammatory Status in Women with Gestational Diabetes: A Randomized Controlled Clinical Trial

1Department of Clinical Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, P.O. Box 14155-6117, Tehran, Iran
2Department of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
3Department of Health Information Management, Mazandaran University of Medical Sciences, Sari, Iran
4Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

Received 23 December 2015; Revised 30 April 2016; Accepted 10 May 2016

Academic Editor: Phillip B. Hylemon

Copyright © 2016 Sadegh Jafarnejad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Sreelakshmi, S. Nair, B. Soman, R. Alex, K. Vijayakumar, and V. Kutty, “Maternal and neonatal outcomes of gestational diabetes: a retrospective cohort study from Southern India,” Journal of Family Medicine and Primary Care, vol. 4, no. 3, p. 395, 2015. View at Publisher · View at Google Scholar
  2. D. B. Carr, K. M. Newton, K. M. Utzschneider et al., “Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia,” Hypertension in Pregnancy, vol. 30, no. 2, pp. 153–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. Dempsey, Z. Ashiny, C.-F. Qiu, R. S. Miller, T. K. Sorensen, and M. A. Williams, “Maternal pre-pregnancy overweight status and obesity as risk factors for cesarean delivery,” The Journal of Maternal-Fetal and Neonatal Medicine, vol. 17, no. 3, pp. 179–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. D. Nitert, H. L. Barrett, K. Foxcroft et al., “SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women,” BMC Pregnancy and Childbirth, vol. 13, article 50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Wendland, M. R. Torloni, M. Falavigna et al., “Gestational diabetes and pregnancy outcomes—a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria,” BMC Pregnancy and Childbirth, vol. 12, article 23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. L. L. Lipscombe, A. T. Banerjee, S. McTavish et al., “Readiness for diabetes prevention and barriers to lifestyle change in women with a history of gestational diabetes mellitus: rationale and study design,” Diabetes Research and Clinical Practice, vol. 106, no. 1, pp. 57–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. P. Palem and P. Abraham, “A study on the level of oxidative stress and inflammatory markers in type 2 diabetes mellitus patients with different treatment modalities,” Journal of Clinical and Diagnostic Research, vol. 9, no. 9, pp. BC04–BC07, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Blaser, “Antibiotic overuse: stop the killing of beneficial bacteria,” Nature, vol. 476, no. 7361, pp. 393–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. D. Wu, J. Chen, C. Hoffmann et al., “Linking long-term dietary patterns with gut microbial enterotypes,” Science, vol. 334, no. 6052, pp. 105–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, “Microbial ecology: human gut microbes associated with obesity,” Nature, vol. 444, no. 7122, pp. 1022–1023, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. G. Redman, E. J. Ward, and R. S. Phillips, “The efficacy and safety of probiotics in people with cancer: a systematic review,” Annals of Oncology, vol. 25, no. 10, pp. 1919–1929, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Reid, J. Jass, M. T. Sebulsky, and J. K. McCormick, “Potential uses of probiotics in clinical practice,” Clinical Microbiology Reviews, vol. 16, no. 4, pp. 658–672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Gionchetti, F. Rizzello, A. Venturi et al., “Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial,” Gastroenterology, vol. 119, no. 2, pp. 305–309, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. R. K. Dhiman, B. Rana, S. Agrawal et al., “Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial,” Gastroenterology, vol. 147, no. 6, pp. 1327–1337.e3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. R. N. Fedorak, B. G. Feagan, N. Hotte et al., “The probiotic vsl#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease,” Clinical Gastroenterology and Hepatology, vol. 13, no. 5, pp. 928–935.e2, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Mastromarino, D. Capobianco, A. Miccheli et al., “Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery,” Pharmacological Research, vol. 95-96, pp. 63–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Rohatgi, V. Ahuja, G. K. Makharia et al., “VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial,” BMJ Open Gastroenterology, vol. 2, no. 1, Article ID e000018, 2015. View at Publisher · View at Google Scholar
  18. S. J. Allen, S. Jordan, M. Storey et al., “Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy,” Journal of Nutrition, vol. 140, no. 3, pp. 483–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Asemi, M. Samimi, Z. Tabassi et al., “Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial,” European Journal of Clinical Nutrition, vol. 67, no. 1, pp. 71–74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Hoffman, C. Nolan, J. D. Wilson, J. J. N. Oats, and D. Simmons, “Gestational diabetes mellitus—management guidelines. The Australasian diabetes in pregnancy society,” The Medical Journal of Australia, vol. 169, no. 2, pp. 93–97, 1998. View at Google Scholar · View at Scopus
  21. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2009. View at Publisher · View at Google Scholar
  22. M. Ljungberg, R. Korpela, J. Ilonen, J. Ludvigsson, and O. Vaarala, “Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes—the PRODIA study,” Annals of the New York Academy of Sciences, vol. 1079, pp. 360–364, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yamano, M. Tanida, A. Niijima et al., “Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats,” Life Sciences, vol. 79, no. 20, pp. 1963–1967, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. D. Cani, S. Possemiers, T. Van de Wiele et al., “Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability,” Gut, vol. 58, no. 8, pp. 1091–1103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Ilmonen, E. Isolauri, T. Poussa, and K. Laitinen, “Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial,” Clinical Nutrition, vol. 30, no. 2, pp. 156–164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. Lindsay, M. Kennelly, M. Culliton et al., “Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study),” The American Journal of Clinical Nutrition, vol. 99, no. 6, pp. 1432–1439, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. K. L. Lindsay, L. Brennan, M. A. Kennelly et al., “Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial,” American Journal of Obstetrics and Gynecology, vol. 212, no. 4, pp. 496.e1–496.e11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. K. Collins, C. Dunne, L. Murphy et al., “A randomised controlled trial of a probiotic Lactobacillus strain in healthy adults: assessment of its delivery, transit and influence on microbial flora and enteric immunity,” Microbial Ecology in Health and Disease, vol. 14, no. 2, pp. 81–89, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Tachon, B. Lee, and M. L. Marco, “Diet alters probiotic Lactobacillus persistence and function in the intestine,” Environmental Microbiology, vol. 16, no. 9, pp. 2915–2926, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. E. S. Yeo, J. Y. Hwang, J. E. Park, Y. J. Choi, K. B. Huh, and W. Y. Kim, “Tumor necrosis factor (TNF-α) and c-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes,” Yonsei Medical Journal, vol. 51, no. 4, pp. 519–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Garcia-Bailo, A. El-Sohemy, P. S. Haddad et al., “Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress,” Biologics: Targets & Therapy, vol. 5, pp. 7–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Matsuzaki, R. Yamazaki, S. Hashimoto, and T. Yokokura, “Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-A(y) mice,” Endocrine Journal, vol. 44, no. 3, pp. 357–365, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Twetman, B. Derawi, M. Keller, K. Ekstrand, T. Yucel-Lindberg, and C. Stecksén-Blicks, “Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid,” Acta Odontologica Scandinavica, vol. 67, no. 1, pp. 19–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Mazloom, A. Yousefinejad, and M. H. Dabaghmanaesh, “Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial,” Iranian Journal of Medical Sciences, vol. 38, no. 1, pp. 38–43, 2013. View at Google Scholar · View at Scopus
  35. M. Mohamadshahi, M. Veissi, F. Haidari, H. Shahbazian, G.-A. Kaydani, and F. Mohammadi, “Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes,” BioImpacts, vol. 4, no. 2, pp. 83–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Asemi, S. Jazayeri, M. Najafi et al., “Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial,” Annals of Nutrition and Metabolism, vol. 60, no. 1, pp. 62–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Hatakka, J. Martio, M. Korpela et al., “Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis—a pilot study,” Scandinavian Journal of Rheumatology, vol. 32, no. 4, pp. 211–215, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Asemi, S. Jazayeri, M. Najafi et al., “Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial,” Pakistan Journal of Biological Sciences, vol. 14, no. 8, pp. 476–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Larsen, F. K. Vogensen, F. W. J. van den Berg et al., “Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults,” PLoS ONE, vol. 5, no. 2, Article ID e9085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Nadal, A. Santacruz, A. Marcos et al., “Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents,” International Journal of Obesity, vol. 33, no. 7, pp. 758–767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Santacruz, A. Marcos, J. Wärnberg et al., “Interplay between weight loss and gut microbiota composition in overweight adolescents,” Obesity, vol. 17, no. 10, pp. 1906–1915, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Wu, C. Ma, L. Han et al., “Molecular characterisation of the faecal microbiota in patients with type II diabetes,” Current Microbiology, vol. 61, no. 1, pp. 69–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” The Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. J.-H. Lee, B. Lee, H.-S. Lee et al., “Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-κB activation in experimental colitis,” International Journal of Colorectal Disease, vol. 24, no. 2, pp. 231–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. X.-Z. Shi, P. F. Lindholm, and S. K. Sarna, “NF-κB activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells,” Gastroenterology, vol. 124, no. 5, pp. 1369–1380, 2003. View at Publisher · View at Google Scholar · View at Scopus